9/25/2006

Merck announced it received European Commission approval for its Gardasil vaccine for the prevention of cervical cancer, the first such vaccine cleared for the European market. Merck plans to market the vaccine through a joint venture with Sanofi Pasteur in 19 European countries.

Related Summaries